Is Caprolactam Chemicals Ltd (507486) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Caprolactam Chemicals Ltd is a average quality company .

Is Caprolactam Chemicals Ltd (507486) undervalued or overvalued?

The key valuation ratios of Caprolactam Chemicals Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone .

What is Caprolactam Chemicals Ltd (507486) share price return in the past 10 years?

Caprolactam Chemicals Ltd share price has appreciated 16.8% annually (CAGR) over the past ten years.

Is Caprolactam Chemicals Ltd (507486) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Caprolactam Chemicals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Caprolactam Chemicals Ltd (507486)?

Company share prices are keep on changing according to the market conditions. The current trading price of Caprolactam Chemicals Ltd (507486) on 07-May-2026 14:49:00 at 14:49 is 52.00.

What is the P/E ratio of Caprolactam Chemicals?

The latest standalone P/E ratio of Caprolactam Chemicals as of 07-May-2026 is 49.52.

What is the P/B ratio of Caprolactam Chemicals Ltd (507486)?

The latest standalone P/B ratio of Caprolactam Chemicals Ltd (507486) as of 07-May-2026 is 4.07.

What is the 52-week high and low of Caprolactam Chemicals Ltd (507486)?

The 52-week high of Caprolactam Chemicals Ltd (507486) is Rs. 81.00 and the 52-week low is Rs. 37.53.

Caprolactam Chemicals Ltd (507486) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Caprolactam Chemicals Ltd (507486)
Brand: Caprolactam Chemicals

Caprolactam Chemicals Ltd (507486) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Key Metrics

Market Cap

₹23 Cr.

P/E Ratio

49.52

Price to Book (P/B)

4.07

Price to Sales (P/S)

2.57

EV/EBITDA

10.56

Return on Capital Employed (ROCE)

-0.44%

Current Price

₹52

Return on Equity (ROE)

-13.66%

Return on Assets (ROA)

-5.46%

Operating Profit Margin

22.6%

Net Profit Margin

-10.52%

Gross Profit Margin

13.4%

Book Value per Share

₹12.5

Sales Growth (YoY)

-3.16%

Sales Growth (3 Years)

48.22%

Operating Profit Growth (1 Year)

-29.95%

Operating Profit Growth (3 Years)

N/A%

Net Profit Growth (1 Year)

-455%

52-Week Low / High

₹38 / 81

Net Profit Growth (3 Years)

N/A%

Dividend Yield

0.00%

Promoter Holding

54.50%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Stock return of Caprolactam Chemicals Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 16.6% based on the current price.

Q.1 Which industry/sub-sector does Caprolactam Chemicals Ltd belong to?

Caprolactam Chemicals Ltd belongs to the Chemicals & Fertilizers sector, operating specifically within the Chemicals segment.

Q.1 Revenue growth of Caprolactam Chemicals Ltd?

Caprolactam Chemicals Ltd revenue growth is -3.2% for FY-2025, which is below its 5-year CAGR of 0.7%, indicating slower growth.

Q.1 Promoter shareholding and pledge status of Caprolactam Chemicals Ltd?

Promoters hold 54.50% of the Caprolactam Chemicals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Caprolactam Chemicals Ltd vs industry peers?

Caprolactam Chemicals Ltd revenue CAGR is 0.70%, compared to the industry median CAGR of 9.62%, indicating slower growth and losing its market share.

DeciZen - make an informed investing decision on Caprolactam Chem

Based on:

Data

M-Cap below 100cr DeciZen not available

Caprolactam Chemicals stock performance

Key Ratios

Is Caprolactam Chemicals Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	27.4%	0.3%	11%	19.6%	25.8%	19.5%	-18.7%	40.3%	6.9%	-0.4%	-
Value Creation Index ⓘ	1.0	-1.0	-0.2	0.4	0.8	0.4	-2.3	1.9	-0.5	-1.0	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	4.9	3.2	4.1	5.2	6.5	6.3	2.1	9.8	7	6.7	9
Sales YoY Gr.	-	-33.6%	25.6%	27.5%	25.4%	-3.1%	-67.2%	375.4%	-29.3%	-3.2%	-
Adj EPS ⓘ	1.1	-0.3	0.4	1.1	2.1	1.4	-2.8	5.5	0.4	-1.5	1
YoY Gr.	-	-121.9%	NA	186.8%	89.9%	-31.9%	-297.9%	NA	-92.2%	-458.1%	-
BVPS (₹) ⓘ	4.3	4.1	4.4	5.5	7.6	8.9	6.1	11.6	12.1	10.5	12.5
Adj Net Profit ⓘ	0.5	-0.1	0.2	0.5	1	0.7	-1.3	2.6	0.2	-0.7	0
Cash Flow from Ops. ⓘ	0.6	0.5	1.1	3	2.2	1.3	3.1	0.9	1.8	-0.6	-
Debt/CF from Ops. ⓘ	1.6	2.6	1.7	1.2	1.1	1.7	1.2	6.6	3.2	-14	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	3.7%	0.7%	48.2%	-3.2%
Adj EPS ⓘ	-203.4%	-194.3%	NA	-458.1%
BVPSⓘ	10.4%	6.7%	20%	-12.9%
Share Price	16.8%	10.1%	-9.4%	21.1%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	30.5	-6	8.9	21.9	31.5	17.2	-37.3	62.6	3.6	-13.7	9
Op. Profit Mgn % ⓘ	17	14.5	22	36.3	38.7	34.3	-27.4	47.5	31.2	22.6	33.4
Net Profit Mgn % ⓘ	10.7	-3.6	4.3	9.7	14.6	10.3	-62	25.9	2.8	-10.5	5.2
Debt to Equity ⓘ	0.5	0.7	0.9	1.4	0.7	0.5	1.3	1.1	1.1	1.8	-
Working Cap Days ⓘ	44	91	123	93	40	54	189	38	62	140	99
Cash Conv. Cycle ⓘ	-7	-12	-9	-35	-39	-6	15	-8	25	89	-42

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	1	-
TTM Sales (₹ Cr.)	9.1	-
BVPS (₹) ⓘ	12.5	-
Reserves (₹ Cr.) ⓘ	1	-
P/BV ⓘ	4.07	-
PE ⓘ	49.52	-

From the Market
52 Week Low / High (₹)	37.53 / 81.00
All Time Low / High (₹)	0.20 / 113.25
Market Cap (₹ Cr.)	23.4
Equity (₹ Cr.)	4.6
Face Value (₹)	10
Industry PE ⓘ	47.8

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Caprolactam Chem - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	4.88	3.24	4.07	5.19	6.51	6.31	2.07	9.84	6.96	6.74
Operating Expenses ⓘ +	4.05	2.77	3.17	3.31	3.99	4.15	2.63	5.17	4.78	5.22
Manufacturing Costs	3.17	2.37	2.17	2.23	2.95	3.25	1.37	3.67	3.32	2.89
Material Costs	0.11	-0.19	0.36	0.37	0.01	0.13	0.53	0.61	0.49	1.34
Employee Cost	0.16	0.16	0.18	0.23	0.23	0.31	0.25	0.35	0.30	0.34
Other Costs ⓘ	0.61	0.44	0.47	0.48	0.80	0.46	0.48	0.54	0.68	0.65
Operating Profit ⓘ	0.83	0.47	0.90	1.88	2.52	2.16	-0.57	4.68	2.17	1.52
Operating Profit Margin (%)	17.0%	14.5%	22.0%	36.3%	38.7%	34.3%	-27.4%	47.5%	31.2%	22.6%
Other Income ⓘ +	0.40	0.01	0.07	0.07	0.06	0.09	0.41	0.02	0.18	0.01
Exceptional Items ⓘ	-0	0	-0	0	0	0	0	0	0	0
Interest ⓘ	0.11	0.12	0.19	0.34	0.30	0.30	0.28	0.57	0.50	0.63
Depreciation ⓘ	0.51	0.47	0.57	0.97	1.02	1.07	1.03	1.15	1.58	1.59
Profit Before Tax ⓘ	0.61	-0.12	0.20	0.64	1.26	0.89	-1.47	2.97	0.27	-0.68
Tax ⓘ	0.09	0	0.03	0.14	0.31	0.24	-0.19	0.42	0.08	0.03
Profit After Tax	0.52	-0.12	0.17	0.50	0.95	0.65	-1.28	2.55	0.20	-0.71
PAT Margin (%)	10.7%	-3.6%	4.2%	9.7%	14.6%	10.3%	-62.0%	25.9%	2.8%	-10.5%
Adjusted EPS (₹)	1.1	-0.3	0.4	1.1	2.1	1.4	-2.8	5.5	0.4	-1.5
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	1.98	1.86	2.03	2.54	3.50	4.08	2.80	5.34	5.55	4.83
Share Capital ⓘ	4.59	4.59	4.59	4.60	4.60	4.60	4.60	4.60	4.60	4.60
Reserves ⓘ	-2.61	-2.73	-2.56	-2.06	-1.10	-0.52	-1.80	0.74	0.95	0.23
Debt +	0.95	1.37	1.89	3.58	2.45	2.15	3.75	5.69	5.86	8.71
Long Term Debt	0	0	0	0	0	0	2.75	2.67	0	0
Short Term Debt	0.95	1.37	1.89	3.58	2.45	2.15	1	3.02	5.86	8.71
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0.50	0.83	0.85	0.81	0.50	0.40	0.50	0.29	0.15	0.44
Others Liabilities ⓘ	0.47	0.26	1.49	0.48	0.66	0.57	3.28	0.20	0.09	0.30
Total Liabilities ⓘ	3.91	4.32	6.27	7.41	7.11	7.20	10.33	11.52	11.65	14.28
Fixed Assets
Net Fixed Assets ⓘ +	2.96	3.38	3.56	6.37	6.07	5.50	5.26	10.22	10.29	10.31
Gross Block	8.27	9.15	9.91	13.68	14.41	14.90	15.70	21.81	23.47	25.13
Accumulated Depreciation	5.31	5.78	6.35	7.32	8.34	9.41	10.44	11.59	13.17	14.82
CWIP ⓘ	0	0	0	0	0	0	3.96	0	0	0
Investments ⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	0.08	0.27	0.30	0.09	0.08	0.11	0.12	0.09	0.07	0.41
Trade Receivables	0.52	0.36	0.77	0.04	0.30	0.47	0.03	0.68	0.64	2.82
Cash Equivalents	0.16	0.11	0.79	0.32	0.34	0.52	0.15	0.23	0.09	0.08
Others Assets ⓘ	0.19	0.20	0.85	0.59	0.32	0.60	0.81	0.31	0.57	0.66
Total Assets ⓘ	3.91	4.32	6.27	7.41	7.11	7.20	10.33	11.52	11.65	14.28

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	0.58	0.54	1.10	2.96	2.18	1.25	3.05	0.86	1.82	-0.62
PBT ⓘ	0.61	-0.12	0.20	0.64	1.26	0.89	-1.47	2.97	0.27	-0.68
Adjustment ⓘ	0.62	0.59	0.76	1.31	1.32	1.35	1.31	1.71	2.07	2.21
Changes in Working Capital ⓘ	-0.55	0.06	0.18	1.13	-0.27	-0.51	3.54	-3.44	-0.44	-2.14
Tax Paid ⓘ	-0.10	0	-0.04	-0.13	-0.13	-0.48	-0.32	-0.38	-0.08	-0
Cash Flow From Investing Activity ⓘ +	-0.56	-0.89	-0.75	-3.78	-0.73	-0.48	-4.75	-2.14	-1.64	-1.60
Capex	-0.56	-0.89	-0.75	-3.78	-0.73	-0.49	-4.75	-2.16	-1.65	-1.61
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	-0.01	0.01	0.01	0.02	0.01	0.01
Cash Flow From Financing Activity ⓘ +	0.02	0.30	0.33	0.35	-1.43	-0.59	1.33	1.37	-0.32	2.22
Net Proceeds from Shares ⓘ	0	0	0	0.01	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-0.10	-0.12	-0.19	-0.34	-0.30	-0.30	-0.28	-0.57	-0.50	-0.63
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0.13	0.42	0.52	0.68	-1.13	-0.30	1.60	1.93	0.18	2.85
Net Cash Flow ⓘ	0.05	-0.05	0.68	-0.47	0.02	0.18	-0.37	0.08	-0.14	-0

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	30.31	-6.01	8.83	21.91	31.49	17.17	-37.28	62.62	3.63	-13.66
ROCE (%)	27.38	0.26	10.97	19.63	25.81	19.53	-18.7	40.26	6.87	-0.44
Asset Turnover Ratio	1.33	0.79	0.77	0.76	0.9	0.88	0.24	0.9	0.6	0.52
PAT to CFO Conversion(x)	1.12	N/A	6.47	5.92	2.29	1.92	N/A	0.34	9.1	N/A
Working Capital Days
Receivable Days	19.90	49.40	50.60	28.50	9.50	22.30	44.40	13.10	34.40	93.70
Inventory Days	9.90	19.40	25.70	13.90	4.90	5.50	20.30	3.90	4.10	12.80
Payable Days	1,324	-1,255.50	850.90	819.20	0	1,260.20	307.50	235.70	164.90	80.20

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Caprolactam Chemicals Ltd FAQs

The current trading price of Caprolactam Chem on 07-May-2026 14:49 is ₹52.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 06-May-2026 the market cap of Caprolactam Chem stood at ₹23.42 Cr

The latest P/E ratio of Caprolactam Chem as of 06-May-2026 is 49.52.

The latest P/B ratio of Caprolactam Chem as of 06-May-2026 is 4.07.

The 52-week high of Caprolactam Chem is ₹81.00 and the 52-week low is ₹37.53.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Caprolactam Chem is ₹9.10 ( Cr.) .

About Caprolactam Chemicals Ltd

Vamotiwala Chemical Industries Limited was originally incorporated on the November 18, 1988 as a Private Limited Company and was converted into a Public Limited Company on the April 15, 1992. Since December 1988, the company has been involved in a phased manner, in activities relating to setting up a project for manufacture of Glycol Ether, Ethylene Oxide Condensate Emulsifier, Vinyl Sulphone and Ethyl Acetate.

The first module of project consisting of Glycol Ether and Ethylene oxide condensate emulsifier plants was put into commercial operation during August 1992. The second module was expected to go on commercial production by fourth quarter of year 1993. In 2008, the companyâ€™s name changed from Vamotiwala Chemical Industries Ltd to Caprolactam Chemicals Ltd.

The company has been promoted by Sarvashri Shankar G Bhanushali, Chandrakant K Pandya, Suresh H Nanda & their associates.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Caprolactam Chemicals Ltd (507486) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Caprolactam Chem Share Price